Trials / Completed
CompletedNCT00839241
A Clinical Study to Investigate if Transfusion of Patients Own Shed Blood Improves the Immunological Status in Comparison to Transfusion of Donor Blood ("Bank Blood")
An Open , Prospective, Randomized, Parallel Group Study to Investigate Whether Postoperatively Collected and Transfused Autologous Whole Blood Improves the Immunological Status in Comparison to Allogenic Blood Transfusion in Patients Undergoing Total Knee Replacement
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Wellspect HealthCare · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the study is to compare the immunological status after either autologous blood transfusion as administered by Bellovac® ABT or allogenic blood transfusion, with regards to change in Natural Killer (NK) cell frequency in patients undergoing total knee replacement.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Bellovac ABT | Bellovac ABT (autologous blood) |
| PROCEDURE | Allogenic Blood Transfusion | Transfusion of allogenic ("bank") blood. |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-06-01
- Completion
- 2009-06-01
- First posted
- 2009-02-09
- Last updated
- 2021-11-11
- Results posted
- 2010-10-04
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT00839241. Inclusion in this directory is not an endorsement.